In a filing, Verona Pharma Plc ADR revealed its President and CEO ZACCARDELLI DAVID unloaded Company’s shares for reported $2.25 million on Sep 11 ’24. In the deal valued at $3.76 per share,600,000 shares were sold. As a result of this transaction, ZACCARDELLI DAVID now holds 15,250,704 shares worth roughly $438.76 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hahn Mark W sold 600,000 shares, generating $2,254,080 in total proceeds. Upon selling the shares at $3.76, the Chief Financial Officer now owns 14,339,688 shares.
Before that, MARK HAHN bought 75,000 shares. Verona Pharma Plc ADR shares valued at $2,103,000 were divested by the Officer at a price of $28.04 per share.
Piper Sandler began covering VRNA with “an Overweight” recommendation on August 26, 2022. H.C. Wainwright started covering the stock on September 13, 2021. It rated VRNA as “a Buy”.
Price Performance Review of VRNA
On Monday, Verona Pharma Plc ADR [NASDAQ:VRNA] saw its stock jump 0.03% to $28.77. Over the last five days, the stock has lost -2.80%. Verona Pharma Plc ADR shares have risen nearly 44.72% since the year began. Nevertheless, the stocks have risen 74.15% over the past one year. While a 52-week high of $30.73 was reached on 09/12/24, a 52-week low of $11.39 was recorded on 05/30/24. SMA at 50 days reached $26.12, while 200 days put it at $18.82.
Levels Of Support And Resistance For VRNA Stock
The 24-hour chart illustrates a support level at 28.29, which if violated will result in even more drops to 27.80. On the upside, there is a resistance level at 29.33. A further resistance level may holdings at 29.88. The Relative Strength Index (RSI) on the 14-day chart is 55.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.94, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.44%. Stochastics %K at 41.52% indicates the stock is a holding.
How much short interest is there in Verona Pharma Plc ADR?
A steep rise in short interest was recorded in Verona Pharma Plc ADR stocks on 2024-09-13, dropping by -1.85 million shares to a total of 8.85 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 10.7 million shares. There was a decline of -20.94%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 25, 2020 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $17 price target.